Description
Pacira BioSciences is a leader in innovative pain management. For over a decade, Pacira has led the way in targeted, non-opioid pain management. Today, we’re building on that legacy with next-generation innovations for chronic, postsurgical and musculoskeletal pain. We’re more than a biotech company; we are a leader in lasting change. Our mission is to deliver innovative, non-opioid pain therapies to transform the lives of patients.
Role with PROBE
Pacira brings extensive clinical and commercial expertise in post-operative pain management and musculockeletal pain management, including osteoarthritis. Through our development and marketing of Zilretta, the development of PCRX-201, a gene therapy for treatment of knee OA, and our extensive registrational OA study, IGOR, we are established leaders in OA clinical research and development. We will be contributing substantially to Biomarker assessment in WP 4 and Clinical Trial design in WP5, including roles as co-leads in WP4.1 and WP5. We are providing supporting roles in WP 1, 3, and 6.
